$2.44T
Total marketcap
$75.6B
Total volume
BTC 50.73%     ETH 15.57%
Dominance

MediPal MEPDF Stock

15.51 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
3.28B USD
LOW - HIGH [24H]
15.51 - 15.51 USD
VOLUME [24H]
600 USD
{{ volume }}
P/E Ratio
13.48
Earnings per share
1.15 USD

MediPal Price Chart

MediPal MEPDF Financial and Trading Overview

MediPal stock price 15.51 USD
Previous Close 13 USD
Open 13 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 13 - 13 USD
52 Week Range 13 - 13.7 USD
Volume 700 USD
Avg. Volume 0 USD
Market Cap 2.88B USD
Beta (5Y Monthly) 0.275478
PE Ratio (TTM) 12.264152
EPS (TTM) 1.15 USD
Forward Dividend & Yield 0.35 (2.67%)
Ex-Dividend Date September 28, 2023
1y Target Est N/A

MEPDF Valuation Measures

Enterprise Value -65604501504 USD
Trailing P/E 12.264152
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.00085591647
Price/Book (mrq) 0.0048623253
Enterprise Value/Revenue -0.02
Enterprise Value/EBITDA -1.031

Trading Information

MediPal Stock Price History

Beta (5Y Monthly) 0.275478
52-Week Change -0.99%
S&P500 52-Week Change 20.43%
52 Week High 13.7 USD
52 Week Low 13 USD
50-Day Moving Average 13 USD
200-Day Moving Average 13.28 USD

MEPDF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 213.82M
Float 195.75M
Short Ratio N/A
% Held by Insiders 9.77%
% Held by Institutions 32.50%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0.33110002
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 1.15%
Operating Margin (ttm) 1.45%
Gross Margin 6.67%
EBITDA Margin 1.89%

Management Effectiveness

Return on Assets (ttm) 1.79%
Return on Equity (ttm) 7.22%

Income Statement

Revenue (ttm) 3.36T USD
Revenue Per Share (ttm) 16002.93 USD
Quarterly Revenue Growth (yoy) 1.09%
Gross Profit (ttm) 224.31B USD
EBITDA 63.62B USD
Net Income Avi to Common (ttm) 38.81B USD
Diluted EPS (ttm) 1.06
Quarterly Earnings Growth (yoy) 1415.70%

Balance Sheet

Total Cash (mrq) 195.03B USD
Total Cash Per Share (mrq) 928.89 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.214
Book Value Per Share (mrq) 2673.618

Cash Flow Statement

Operating Cash Flow (ttm) 16.15B USD
Levered Free Cash Flow (ttm) -11890499584 USD

Profile of MediPal

Country United States
State N/A
City Tokyo
Address 2-7-15, Yaesu
ZIP 104-8461
Phone 81 3 3517 5800
Website https://www.medipal.co.jp
Industry Medical Distribution
Sector(s) Healthcare
Full Time Employees N/A

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

Q&A For MediPal Stock

What is a current MEPDF stock price?

MediPal MEPDF stock price today per share is 15.51 USD.

How to purchase MediPal stock?

You can buy MEPDF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for MediPal?

The stock symbol or ticker of MediPal is MEPDF.

Which industry does the MediPal company belong to?

The MediPal industry is Medical Distribution.

How many shares does MediPal have in circulation?

The max supply of MediPal shares is 211.28M.

What is MediPal Price to Earnings Ratio (PE Ratio)?

MediPal PE Ratio is 13.48695700 now.

What was MediPal earnings per share over the trailing 12 months (TTM)?

MediPal EPS is 1.15 USD over the trailing 12 months.

Which sector does the MediPal company belong to?

The MediPal sector is Healthcare.